Impact of vaccination on new SARS-CoV-2 infections in the UK

Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Owen Gethings, Karina-Doris Vihta, Joel Jones, Thomas House, Harper VanSteenHouse, Iain Bell, John I Bell, John N Newton, Jeremy Farrar, Ian Diamond, Emma Rourke, Ruth Studley, Derrick Crook, Tim Peto, A. Sarah Walker, Koen B. Pouwels
doi: https://doi.org/10.1101/2021.04.22.21255913

Article Information

doi 
https://doi.org/10.1101/2021.04.22.21255913
History 
  • June 9, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Emma Pritchard1,2,
  2. Philippa C. Matthews1,3,4,
  3. Nicole Stoesser1,2,3,4,
  4. David W. Eyre2,3,4,5,
  5. Owen Gethings6,
  6. Karina-Doris Vihta1,2,
  7. Joel Jones6,
  8. Thomas House7,8,
  9. Harper VanSteenHouse9,10,
  10. Iain Bell6,
  11. John I Bell11,
  12. John N Newton12,
  13. Jeremy Farrar13,
  14. Ian Diamond6,
  15. Emma Rourke6,
  16. Ruth Studley6,
  17. Derrick Crook1,2,3,4,
  18. Tim Peto1,2,3,4,
  19. A. Sarah Walker#,1,2,3,14 and
  20. Koen B. Pouwels#,2,5,15,*
  1. 1Nuffield Department of Medicine, University of Oxford, Oxford, UK
  2. 2The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK
  3. 3The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
  4. 4Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
  5. 5Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  6. 6Office for National Statistics, Newport, UK
  7. 7Department of Mathematics, University of Manchester, Manchester, UK
  8. 8IBM Research, Hartree Centre, Sci-Tech Daresbury, UK
  9. 9Glasgow Lighthouse Laboratory, Glasgow, UK
  10. 10Bioclavis Ltd, Glasgow, UK
  11. 11Office of the Regius Professor of Medicine, University of Oxford, Oxford, UK
  12. 12Health Improvement Directorate, Public Health England, London, UK
  13. 13Wellcome Trust, London, UK
  14. 14MRC Clinical Trials Unit at UCL, UCL, London, UK
  15. 15Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  1. ↵*Corresponding author: Koen B. Pouwels, koen.pouwels{at}ndph.ox.ac.uk

  1. ↵# These authors contributed equally

Back to top
Posted June 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Impact of vaccination on new SARS-CoV-2 infections in the UK
Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, David W. Eyre, Owen Gethings, Karina-Doris Vihta, Joel Jones, Thomas House, Harper VanSteenHouse, Iain Bell, John I Bell, John N Newton, Jeremy Farrar, Ian Diamond, Emma Rourke, Ruth Studley, Derrick Crook, Tim Peto, A. Sarah Walker, Koen B. Pouwels
medRxiv 2021.04.22.21255913; doi: https://doi.org/10.1101/2021.04.22.21255913
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area